Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0B0MA
|
|||
Former ID |
DIB005880
|
|||
Drug Name |
F-2692
|
|||
Synonyms |
AC1L2OTQ; F 2692; ZINC6069558; AKOS022768604; 3-amino-6-methyl-1-[4-(trifluoromethyl)phenyl]pyridazin-4-one
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Anxiety disorder [ICD-11: 6B00-6B0Z; ICD-10: R45.0] | Discontinued in Phase 1 | [1] | |
Company |
Pierre Fabre SA
|
|||
Structure |
Download2D MOL |
|||
Formula |
C12H10F3N3O
|
|||
Canonical SMILES |
CC1=CC(=O)C(=NN1C2=CC=CC(=C2)C(F)(F)F)N
|
|||
InChI |
1S/C12H10F3N3O/c1-7-5-10(19)11(16)17-18(7)9-4-2-3-8(6-9)12(13,14)15/h2-6H,1H3,(H2,16,17)
|
|||
InChIKey |
MRMGTEKECRMLOG-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001416) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.